Sana Biotechnology (SANA) Invested Capital (2021 - 2026)

Sana Biotechnology has reported Invested Capital for 5 years, with the latest figure at $53.6 million in Q1 2026.

• Quarterly Invested Capital changed N/A year-over-year to $53.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93.8 million (changed N/A YoY) and the FY2025 annual result came in at $40.2 million, changed N/A from the prior year.
• Invested Capital advanced to $53.6 million in Q1 2026 per SANA's latest filing, from $40.2 million in the prior quarter.
• Over five years, Invested Capital peaked at $59.4 million in Q3 2022 and troughed at $40.2 million in Q4 2025.
• A 4-year average of $53.3 million and a median of $54.5 million in 2022 frame the typical range for Invested Capital.
• The widest YoY moves for Invested Capital: up 36.75% in 2022, down 7.71% in 2022.
• Over 4 years, Invested Capital stood at $55.3 million in 2022, then rose by 5.55% to $58.4 million in 2023, then sank by 31.18% to $40.2 million in 2025, then soared by 33.22% to $53.6 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $53.6 million, $40.2 million, and $58.4 million for Q1 2026, Q4 2025, and Q2 2023 respectively.